Mersaco - News & Release - Ismigen

Ismigen

15 June 2015

Lallemand pharma and Mersaco sal are pleased to introduce Ismigen in the Lebanese market.
Ismigen is a polyvalent Mechanical Bacterial Lysate (PMBL), also described as oral vaccine. It is recommended in the prevention of acute, sub-acute, recurrent or chronic infections of the upper and lower airways and the bronchpulmonary tree.